Eli Lilly Gets Expanded Label Approval From FDA for Alopecia Drug
Dow Jones2026/09/25 21:26By Elias Schisgall
Eli Lilly received expanded label approval from the Food and Drug Administration for Olumiant, a drug for pediatric patients 12 years of age or older with severe alopecia areata.
The company said Friday that the FDA had approved the expanded U.S. label for the drug, known generically as baricitinib, based on the results of a Phase 3 study. Olumiant was previously approved for adults with moderately to severely active rheumatoid arthritis and severe alopecia areata.
"The visible and often extensive hair loss that comes with severe alopecia areata can have a profound impact on anyone, especially adolescents who are at a pivotal stage of life," Lilly Immunology president Adrienne Brown said. "Expanding Olumiant to patients as young as 12 provides them a much-needed treatment choice and reinforces our commitment to advancing care for people living with immune-mediated diseases."
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
September 25, 2026 17:26 ET (21:26 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December
Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.
Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation
The Federal Reserve Eyes $1.8 Trillion in “Shadow Credit”: Dallas and New York Fed Launch First Private Credit Survey
The Dallas and New York Federal Reserves have launched an investigation into private credit lending standards, covering an industry worth 1.8 trillions USD, with a minimum threshold of 50 millions USD. The results will be released in the first quarter of 2027.
Tom Lee Says a VIX Signal Points to a Stock Market Bottom
Crypto prices
More
